Physician profile
Ryan E Browning
NPI 1194901355
$763.58
in general payments reported to CMS, 2019-2025
10 companies · $16.23 in 2025
The $16.23 reported for 2025 was less than what a typical Nurse Anesthetist, Certified Registered provider received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $167 · 2022: $164 · 2023: $72.15 · 2024: $344 · 2025: $16.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $431.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $210.83 | 2021-2024 | Hemosphere |
| Abbott Laboratories | $199.26 | 2021-2025 | Sjm Regent |
| Becton, Dickinson and Company | $150.00 | 2024 | Hemosphere |
| Merck Sharp & Dohme LLC | $63.21 | 2022-2023 | |
| Elutia, INC. | $44.70 | 2021-2022 | |
| Medtronic, INC. | $30.65 | 2023 | Corevalve Evolut R |
| Takeda Pharmaceuticals U.S.A., INC. | $20.92 | 2023 | Entyvio |
| Janssen Biotech, INC. | $18.66 | 2022 | |
| Teleflex LLC | $13.21 | 2022 | |
| Atricure, INC. | $12.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Browning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.